3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy

Table 1 Baseline clinical characteristics of patients with chronic hepatitis B virus infection-related liver cirrhosis

Clinical features	Values1
Total number	55
Age (yr)	53.2 ± 9.3
Sex , male: female	34:21
Body mass index (kg/m2)	24.0 ± 2.5
Diabetes mellitus	11 (20.0)
Laboratory results
WBC (× 103/μL)	4507.6 ± 1703.3
Hemoglobin (g/dL)	13.2 ± 1.8
Platelet (× 103/μL)	91.9 ± 51.9
Prothrombin time (INR)	1.4 ± 0.3
Total bilirubin (mg/dL)	2.1 ± 2.0
AST (IU/L)	115.7 ± 118.2
ALT (IU/L)	109.8 ± 151.8
ALP	218.5 ± 89.0
GGT	100.8 ± 94.5
Albumin (g/dL)	3.5 ± 0.6
Creatinine	0.8 ± 0.2
AFP	142.4 ± 299.4
HBeAg positive	34 (61.8)
HBV DNA (log IU/mL)	5.8 ± 1.2
CTP score	7.8 ± 2.3
CTP grade (A/B/C)	21 (38.2)/21 (38.2)/13 (23.6)
MELD score	9.0 ± 4.9

¹Expressed by mean ± SD or number (percent). WBC: White blood cell; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; GGT: Gamma glutamyl transpeptidase; AFP: Alpha fetoprotein; HBeAg: Hepatitis B e antigen; CTP: Child-Turcotte-Pugh; MELD: Model for end-stage liver disease.